Businesses thrive by knowing customer insights, because today’s insights are tomorrow's facts. At iResearch we live and breathe insights. And despite searching high and low, we were unable to find a customer insights podcast that answers one of the most important questions in business: why do customers do what they do? So we launched one.
…
continue reading
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
…
continue reading
Dear Friends I shall be presenting poems &Songs of famous writers of Hindi in this series.
…
continue reading
Sharing my life stories, experiences, and motivational teachings and wisdom. Early in my life I survived a life threatning illness where I was given no chance to live more the 6 months. That was 26 years ago....... Cover art photo provided by Oleg Laptev on Unsplash: https://unsplash.com/@snowshade
…
continue reading
SWAMINARAYAN SAMPRADAY SAHITYA DARSHAN SANATAN DHARM PRAVARTAK SARVOPARI SHRI SWAMINARAYAN BHAGWAN NA DIVYA LILA CHARITRA SABHAR SAHITYA. OUR SPIRITUAL HISTORY OUR ANCIENT ART OUR CULTURE OUR HUMAN ENTITY
…
continue reading
Sri Birendra Chandra Chakraborty, His Excellency was well known to the general mass as Param Pita Janmasiddyha Thakur Sri Sri Balak Brahmachari Maharaj. Sri Sri Thakur's disciples, devotees, followers and impassioned counts to 25 Crores in India itself. During his tenure, many great men of different name and fame from various castes, creeds and sects of the society had the opportunity to seek His blessings.The Great Hymn “RAM NARAYAN RAM” was given by Sri Sri Thakur which is the revamp of “H ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Personalized Corporate Gifting: A Conversation with Millie Tadewaldt of Brilliant
42:05
42:05
Play later
Play later
Lists
Like
Liked
42:05
In this episode of Getting to Aha!, Darshan Mehta is joined by Millie Tadewaldt, the founder and CEO of Brilliant. Join them as they discuss personalized corporate gifting, the need for technology in the gifting process, and the measurement of ROI. Millie Tadewaldt is the founder and CEO of Brilliant, a company specializing in personalized corporat…
…
continue reading
Subscriber-only episode We dive into the critical issue of racial bias in AI, highlighted by a recent Yale study focusing on ChatGPT. This has significant implications for clinical research sponsors, sites, and principal investigators. We also explore the FDA's perspective on AI in clinical trials, presented by Dr. Elzarrad. Overview of the Yale St…
…
continue reading
Today we're diving into a critical issue that has shaken the pharmacy world. Recently, a pharmacy owner was sentenced for paying illegal kickbacks and engaging in a money laundering conspiracy. This case has significant implications for promotional compliance within the pharmacy industry, and we're here to explore them in detail. In a landmark case…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] Boosting Customer Experience through Behavioural Insights with Andrew Custage, Head of Insights at Medallia Market Research
43:37
43:37
Play later
Play later
Lists
Like
Liked
43:37
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Andrew Custage, Senior Director and Head of Insights at Medallia Market Research. Join them as they discuss striking a balance between qualitative and quantitative data, customizing survey questions, and differentiating between active customers and inactive customer…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Navigating FDA's clinical trial expectations after approval
3:25
3:25
Play later
Play later
Lists
Like
Liked
3:25
Today, we're diving into the FDA's Fiscal Year 2022 report on postmarketing requirements (PMRs) and postmarketing commitments (PMCs). PMRs are mandatory studies required by the FDA after a drug's approval, focusing on real-world data for long-term safety and effectiveness. Think of them as an extension of the initial research phase, but in a real-w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Do dietary supplements interact with drugs?
0:59
0:59
Play later
Play later
Lists
Like
Liked
0:59
Do dietary supplements interact with drugs? Many people think only prescription drugs can cause interactions, but dietary supplements can too. From an FDA perspective, a drug is defined by its claims and indications. Some supplements make drug-like claims and can interact with medications. Common examples include grapefruit juice and vitamin K, whi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Moringa: A Conversation with Lisa Curtis of Kuli Kuli Foods
34:46
34:46
Play later
Play later
Lists
Like
Liked
34:46
In this episode of @Getting to Aha!, @Darshan Mehta is joined by @Lisa Curtis, founder and CEO of Kuli Kuli Foods. Join them as they discuss Lisa's journey in promoting nutritious and sustainable food products, the challenges of sourcing high-quality ingredients, and her commitment to paying it forward. Lisa is the founder and CEO of Kuli Kuli Food…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Expert Pharma Marketers Navigate Privacy
1:26
1:26
Play later
Play later
Lists
Like
Liked
1:26
In today's consumer landscape, privacy concerns reign supreme. Pharmaceutical and medical device manufacturers must prioritize meeting the expectations of this privacy-conscious generation. This begins with three key measures: 1. Consent Management: Clear communication about data usage is essential, aligning with regulations like CCPA and GDPR. See…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hiring New Employees in PharmaTech Companies
22:05
22:05
Play later
Play later
Lists
Like
Liked
22:05
Edye Edens, a consultant and attorney with a background in regulatory affairs, shared insights into her unexpected yet exciting role at Weave, a rapidly growing startup specializing in AI-driven solutions for regulatory content creation. Edye discussed her journey from freelance consultancy to joining Weave, highlighting the unique challenges and o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] The Simpler Retail is, the More Successful it Will Be with Sanjai George, CEO of Double Horse
39:19
39:19
Play later
Play later
Lists
Like
Liked
39:19
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Sanjai George, CEO of Double Horse. Join them as they discuss effective communication and simplicity in retail, the value of adapting to the changing retail landscape, and why customer feedback is so important. Sanjai also discusses the changes and trends that have …
…
continue reading
In this episode, we discuss how drug and device manufacturers may seem to collaborate with telemedicine companies to market products and ensure patient needs are met conveniently. However, there are three major concerns: 1. Ignoring Pharma Laws: Telehealth companies might not adhere to pharma marketing laws and could act as agents for pharma due to…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why a food lawyer would stop your restaurant’s marketing?
1:38
1:38
Play later
Play later
Lists
Like
Liked
1:38
Today, we're tackling a critical issue for restaurants and food marketers: promotional compliance and the risks of misbranding, as highlighted by a recent case in Biloxi. Mary Mahoney's Old French House Restaurant and its co-owner, Anthony Charles Savanovich, recently pled guilty to conspiracy and misbranding seafood. Over six years, they sold over…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Following Your Passion: Greg Segal's Journey from Lawyer to Filmmaker
37:33
37:33
Play later
Play later
Lists
Like
Liked
37:33
In this episode of @Getting to Aha!, Darshan Mehta is joined by Greg Segal, a writer/director and producer. Join them as they discuss Greg's journey from lawyer to filmmaker, the value of contemplating life choices, and his involvement in producing vertical movies for platforms like TikTok. Greg Segal is a writer/director and producer based in New …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Why are there chemo drug shortages?
0:52
0:52
Play later
Play later
Lists
Like
Liked
0:52
We discuss how the shortage of chemotherapy drugs stems from economic challenges faced by generic drug manufacturers. Many cannot afford to produce these drugs due to low profitability. Factors include factory shutdowns for quality issues, a complex global supply chain, and older generic drugs being unprofitable to produce. Government pressure on p…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Are Pharma Giants Ignoring Clinical Trial Site Issues?
30:10
30:10
Play later
Play later
Lists
Like
Liked
30:10
In this episode, Daniel Fox discusses the key challenges faced by research sites, including trust issues, payment delays, and operational setbacks. He emphasizes initiatives like the "Open Mic" policy for anonymous feedback and the grassroots movement Save Our Sites (SOS). Dr. Fox also explores issues with decentralized clinical trials, advocates f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] Turning a Hobby into a Career with Jim Turner and Steve Sidelnyk
39:55
39:55
Play later
Play later
Lists
Like
Liked
39:55
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Steve Sidelnyk, highly accomplished session drummer and music programmer, and Jim Turner, an experienced entertainment industry professional. Join them as they discuss the importance of standing out in a competitive industry, the importance of curiosity and learning…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Adverse Events Go Unreported in Clinical Trials
1:51
1:51
Play later
Play later
Lists
Like
Liked
1:51
In clinical trials, reporting adverse events and protocol deviations is crucial for patient safety and trial integrity. However, some sites may hesitate to report due to concerns about trial disruption, revenue loss, and increased scrutiny. This reluctance can lead to serious consequences, as seen in cases where significant events like hives, disru…
…
continue reading
In this episode, we delved into the pivotal role of patient advocates within the pharmaceutical industry. Patient advocates are champions who ensure that patients' voices are not only heard but also central to decisions affecting their health. They play a crucial role in various aspects: Firstly, patient advocates are instrumental in representing t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Importance of Empathy in Sales Management: Insights from Alan Versteeg, Global Chief Revenue Officer at Growth Matters
33:14
33:14
Play later
Play later
Lists
Like
Liked
33:14
In this episode of Getting to Aha!, Darshan Mehta is joined by Alan Versteeg, Global Chief Revenue Officer at Growth Matters. Join them as they discuss conveying customer value, the use of generative AI, and the role of empathy in sales. Alan also touches on the future of sales, and the role of sales managers. Alan Versteeg is an engineer turned sa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Drug Accountability Matters in Clinical Trials
1:43
1:43
Play later
Play later
Lists
Like
Liked
1:43
Drug accountability is a critical aspect monitored by the FDA at clinical trial sites. Principal investigators must maintain and document control over investigational products, ensuring they are only administered under direct supervision. Clinical research organizations also conduct routine audits to verify drug accountability. However, instances o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: What do I do if my med is on shortage?
0:47
0:47
Play later
Play later
Lists
Like
Liked
0:47
We discuss how to address drug shortages. First things first, it's important to stay calm. Just because there's a shortage doesn't mean you'll lose access to your medication entirely. Here are some action steps you can take: 1. Schedule an appointment with your doctor to discuss alternative medications that might be effective for you. It's crucial …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
5 reasons not to use AI in creating pharma marketing content
1:26
1:26
Play later
Play later
Lists
Like
Liked
1:26
We discuss the risks associated with using AI in your pharma marketing plans: 1. Data Privacy and Security: Ensuring the security and privacy of data, whether it pertains to patients or non-patients, is paramount. 2. Bias: Questions arise regarding the sources of information, control over data, and addressing privacy concerns to prevent biases and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
8 essential elements of a valid prescription
1:03
1:03
Play later
Play later
Lists
Like
Liked
1:03
In this episode, we discussed eight essential strategies to prevent prescription drug fraud and abuse: Verify the prescriber's identity. Know the prescriber's DEA number. Know your patient thoroughly. Verify prescription dates for validity; ensure prescriptions are current. Communicate directly with prescribers if any concerns arise. Request identi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] How Twitter Changed the Branding Game with Brandon Rhoten, CMO at GroundTruth
42:29
42:29
Play later
Play later
Lists
Like
Liked
42:29
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Brandon Rhoten, Chief Marketing Officer at GroundTruth. Join them as they discuss the impact of social media in humanizing brands, why digital marketing channels should be seen as tools to solve specific brand problems, and leveraging customer insights beyond surfac…
…
continue reading
In this episode we're joined by Heather McFalls, Director of Promotion Compliance at Otsuka Pharmaceutical Companies to discuss the evolving role of ad promo executives and the regulatory landscape in the pharmaceutical industry. Dive into the conversation as we explore the impact of regulatory bodies like the FDA, FTC, and NAD, and the importance …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: 4 Ways to Get Unapproved Drugs Legally!
0:53
0:53
Play later
Play later
Lists
Like
Liked
0:53
Today, we discuss four legal pathways to acquire unapproved drugs. First, over-the-counter drugs offer a route as some bypass FDA approvals, relying instead on a nomograph. Second, compounded drugs crafted by pharmacists provide an alternative despite lacking FDA approval. Third, the FDA's new policy allows for state-imported drugs, provided certai…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Disruptive Innovation in the Restaurant Industry: Insights from Steve Bigari, EVP, AI for Restaurants at Soundhound
33:35
33:35
Play later
Play later
Lists
Like
Liked
33:35
In this episode of Getting to Aha!, Darshan Mehta is joined by Steve Bigari, the EVP, AI for Restaurants at Soundhound. Join them as they discuss how technology, particularly AI, can enhance the restaurant experience, the mindset needed to be a disruptor in the industry, and the importance of removing friction from the customer's life. Steve also s…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The 4 Building Blocks of Using AI in any Pharma Marketing Strategy
0:53
0:53
Play later
Play later
Lists
Like
Liked
0:53
We discuss the essential elements to ensure that your pharma marketing plan aligns with AI use: 1. Define Clear Goals: Establishing clear objectives is crucial for developing a comprehensive compliance plan for AI use. Without clear goals, executing a successful strategy becomes challenging. 2. Establish Policies and Procedures: Clearly defined pol…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Why Clinical Trials Are Right for You!
0:58
0:58
Play later
Play later
Lists
Like
Liked
0:58
In this short, we explore four key reasons to get involved in clinical research. First, it offers potential access to cutting-edge therapies, though it's important to note you might only receive the standard of care. Second, participation ensures closer monitoring by healthcare professionals. Third, it provides an opportunity to contribute to medic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Clinical Researchers Are Flocking to MedSpas
32:13
32:13
Play later
Play later
Lists
Like
Liked
32:13
In today’s episode, our guest is Andrew Stein, a partner in the healthcare department at Stevens and Lee . Darshan and Andrew discuss MedSpas. MedSpas combine beauty treatments with medical procedures, blurring the lines between pampering and healthcare. To navigate this complexity, they talk about MSOs, which are basically middlemen. MSOs let non-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] Exploring the Power of the Subconscious with Shalini Josh Yamdagni of EFT Thailand
47:56
47:56
Play later
Play later
Lists
Like
Liked
47:56
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Shalini Joshi Yamdagni, Chronic Pain Relief Expert at EFT Thailand. Join them as they explore helping people with chronic pain find relief through alternative approaches, the power of emotions in influencing physical wellbeing, and the use of Emotional Freedom Techn…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Why You Should Never Trust a Celebrity with Your Health
0:51
0:51
Play later
Play later
Lists
Like
Liked
0:51
Darshan explains why you shouldn’t Trust Celebrities When Choosing Your Drugs! Hidden Agendas: They're paid to promote, not give unbiased advice. Not Medical Experts: Trust your doctor's knowledge, not a celebrity's opinion. Oversimplified Info: 30-second ads can't tell the whole story. Not Personalized: Your doctor can give you the right advice fo…
…
continue reading
Recent pharmacy walkouts and closures at major chains highlight a critical issue: staffing shortages. Independent pharmacies are also at risk. Here are 5 tips for pharmacy owners and managers to prepare for potential temporary closures: Cross-Train Staff: Train front-end staff on basic pharmacy procedures (depending on state regulations) so they ca…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Exploring the World: A Journey of Aha! Moments with Heath Tredell of Bablake House Limited
39:57
39:57
Play later
Play later
Lists
Like
Liked
39:57
In this episode of Getting to Aha!, Darshan Mehta is joined by Heath Tredell, the Managing Director of Bablake House Limited. Join them as they discuss formative Aha! moments, retiring early, and prioritizing experiences over possessions. Heath Tredell is the Managing Director of Bablake House Limited, a family-owned residential home that offers ho…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: 5 Surprising Benefits of Ozempic!
0:45
0:45
Play later
Play later
Lists
Like
Liked
0:45
We dive deep into 5 uses of Ozempic, a drug known for managing diabetes, but with surprising potential beyond! Here are 5 intriguing uses you might not have heard of: Liver Support: Early research suggests Ozempic could benefit liver health, but more studies are needed. Weight Loss Weapon: Ozempic has a weight-loss version, offering a powerful tool…
…
continue reading
In today's episode, we discuss AI-generated content in the pharmaceutical industry. AI has revolutionized content creation, but it's not without its legal and ethical dilemmas. Take, for instance, the New York Times' lawsuit against OpenAI, highlighting the contentious issue of data ownership. As pharma companies increasingly rely on AI for content…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Why does my drug cost so much?
0:48
0:48
Play later
Play later
Lists
Like
Liked
0:48
In today’s short, Darshan discusses why drugs cost so much. It takes around 10 to 15 years and roughly $2.3 billion to bring a drug to market. That means a drug company spends between $420,000 and $630,000 daily during this process. Imagine going to a casino every day, betting that much money without knowing the outcome, for 10 to 15 years. What ki…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] Mastering Influencer Marketing for Business Growth with Prateek Panda, VP of Marketing at Phyllo
44:39
44:39
Play later
Play later
Lists
Like
Liked
44:39
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Prateek Panda, VP of Marketing at Phyllo. join them as they explore the importance of customer insights, the importance of authenticity, and the future of the industry. Prateek also shares valuable insights and advice for businesses looking to leverage influencers f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI for Promotions in FDA-Regulated Industries
0:57
0:57
Play later
Play later
Lists
Like
Liked
0:57
Join Darshan Kulkarni, a Food and Drug attorney, as he explores the dynamic intersection of artificial intelligence, drug and device promotion, and the law. In this podcast series, we'll dive deep into AI's role in promotional and non-promotional communications within the pharmaceutical and medical device industries. From regulatory compliance and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Billion-Dollar Speaker Scheme!
0:44
0:44
Play later
Play later
Lists
Like
Liked
0:44
Speaker programs are events sponsored by drug and device companies where a physician or other healthcare professional (HCP) delivers a speech or presentation to fellow HCPs regarding a specific drug, device product, or disease state on behalf of the sponsoring company. Typically, the company compensates the speaker with an honorarium and may also p…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Off-Label Risks: Compliance Matters Now More Than Ever
24:35
24:35
Play later
Play later
Lists
Like
Liked
24:35
We shed light on the complexities surrounding off-label promotion and reimbursement in the pharmaceutical industry. We discuss the following: What does off-label mean from a reimbursement standpoint? Lessons from the US v. Eli Lilly 2009 case How do recent court decisions impact off-label promotion? United States v. Caronia and US v. Facteau How ar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Misconceptions and Realities: Exploring Performance Enhancement with Dustin Elliott of the Vitamin Shoppe
43:00
43:00
Play later
Play later
Lists
Like
Liked
43:00
In this episode of Getting to Aha!, Darshan Mehta is joined by Dustin Elliott, the Senior Brand Manager at The Vitamin Shoppe. Join them as they explore misconceptions about performance enhancement, the impact of gut health on overall wellbeing, emerging trends in the supplements industry, and the future of nutrition and healthcare. Dustin Elliott …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
6 Must-Knows Before Buying a Drug or Device Company
1:31
1:31
Play later
Play later
Lists
Like
Liked
1:31
Buying a Drug or Device Company? 6 Compliance Must-Knows Thinking of acquiring a drug or device company? Buckle up! This deal requires serious compliance considerations. Here's a quick rundown: The DOJ offers a 6-month "safe harbor" for confessing past compliance issues. Use it! The DOJ demands strong compliance programs with thorough risk assessme…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Are there chemo drug shortages?
0:50
0:50
Play later
Play later
Lists
Like
Liked
0:50
We discuss how recent shortages of chemotherapy drugs like cisplatin and carboplatin have caused delays and changes in treatment plans for some cancer patients. While the situation is improving, shortages still exist for some drugs. Staying informed is crucial, and the FDA is actively tracking drug shortages to mitigate them. It's important to comm…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: Don’t Ignore State Registrations
0:35
0:35
Play later
Play later
Lists
Like
Liked
0:35
We discuss how failure to register with the appropriate state boards of Pharmacy as a drug or device manufacturer can lead to severe consequences. These consequences include 1. Hefty fines, revoked licenses, and even legal charges, potentially ruining your business. 2. Additionally, non-compliance can result in reputational damage, eroding public t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Greatest Hits] Experiences Beyond the Product with Experiential Designer, Xuan Xu
52:06
52:06
Play later
Play later
Lists
Like
Liked
52:06
In this ‘Greatest Hits’ episode of Getting to Aha!, Darshan Mehta was joined by Xuan Xu, Managing Director of Xuan Xu Experiences. Together they explore why the accessibility of commodities and the rise of digitalization means consumers seek unique and memorable experiences, as well as the challenges faced by experiential designers. Xuan also discu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: 6 Crucial Mistakes in Informed Consent
0:59
0:59
Play later
Play later
Lists
Like
Liked
0:59
We discuss six critical errors in the informed consent process: 1. Exclusion of Principal Investigator: PI was not allowed to engage in the informed consent process. 2. Lack of Detailed Discussion: Staff members did not take the time to thoroughly discuss the study's potential benefits and risks with prospective subjects. 3. Inadequate Training: Co…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Building Brands through Creative Storytelling: Lessons from Matt Swieca of The Martin Agency
30:36
30:36
Play later
Play later
Lists
Like
Liked
30:36
In this episode of Getting to Aha!, Darshan Mehta is joined by Matt Swieca, Executive Producer/Program Director at The Martin Agency. Join them as they discuss the importance of customer insights, storytelling, and adapting to the evolving landscape of digital marketing and advertising. Matt shares valuable insights into the industry and the strate…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Legal Minute: What is informed consent in clinical trials?
0:46
0:46
Play later
Play later
Lists
Like
Liked
0:46
Informed consent is a crucial aspect of clinical trials, ensuring that prospective subjects understand the benefits, risks, and potential harms of participating in a study. This process involves full disclosure of information, allowing subjects to ask questions and address concerns with a knowledgeable medical professional. For minors, parental inv…
…
continue reading